, yet the underlying mechanisms are not understood. To this end, we have cloned smooth muscle zipper-interacting protein (ZIP) kinase cDNA. ZIP kinase is present in various smooth muscle tissues including arteries. Triton X-100 skinning did not diminish ZIP kinase content, suggesting that ZIP kinase associates with the filamentous component in smooth muscle. Smooth muscle ZIP kinase phosphorylated smooth muscle myosin as well as the isolated 20-kDa myosin light chain in a Ca 2؉ /calmodulinindependent manner. ZIP kinase phosphorylated myosin light chain at both Ser 19 and Thr 18 residues with the same rate constant. The actin-activated ATPase activity of myosin increased significantly following ZIP kinaseinduced phosphorylation. Introduction of ZIP kinase into Triton X-100-permeabilized rabbit mesenteric artery provoked a Ca 2؉ -free contraction. A protein phosphatase inhibitor, microcystin LR, also induced contraction in the absence of Ca 2؉ , which was accompanied by an increase in both mono-and diphosphorylation of myosin light chain. The observed sensitivity of the microcystin-induced contraction to various protein kinase inhibitors was identical to the sensitivity of isolated ZIP kinase to these inhibitors. These results suggest that ZIP kinase is responsible for Ca 2؉ independent myosin phosphorylation and contraction in smooth muscle.
Smooth muscle contraction is primarily regulated by the phosphorylation of myosin at its regulatory light chain (1) (2) (3) (4) . The protein kinase responsible for myosin phosphorylation is a Ca 2ϩ /calmodulin-dependent myosin regulatory light chain-specific protein kinase, myosin light chain kinase (MLCK) 1 (1) (2) (3) (4) . Accordingly, a change in cytosolic Ca 2ϩ concentration changes the kinase activity, thus regulating smooth muscle contraction. On the other hand, the other component of myosin phosphorylation regulation, myosin light chain phosphatase (MLCP), was originally assumed to be itself unregulated. Recent studies have revealed that this is not the case and that MLCP is regulated by various signaling pathways. MLCP consists of three subunits, a myosin-binding large subunit (MBS), a 20-kDa small subunit, and a catalytic subunit of the type 1 protein serine/threonine phosphatase family (5) . It has been shown that MBS can be phosphorylated by Rho-dependent kinase, which results in a decrease in MLCP activity (6) ; therefore, it has been postulated that an activation of the Rho signaling pathway would down-regulate MLCP and thus increase contraction. It was also shown that the activation of protein kinase C (PKC) inhibits MLCP, thus inducing contraction (7) . This suggests that MLCP is regulated by a membrane-associated large G-protein signaling pathway acting via activation of phospholipase C to produce diacylglycerol, an activator of PKC. Subsequently, it was suggested that the PKC-induced increase in contraction is due to an activation of MLCP-specific inhibitor protein, CPI17, by PKC-mediated phosphorylation (8) . It was also found that arachidonic acid could directly interact with MLCP to induce the dissociation of the MBS from the MLCP holoenzyme. The dissociation of the MBS results in a decrease in the phosphatase activity (9) .
It has been known that agonist stimulation evokes larger force than high K ϩ stimulation with a given cytosolic Ca 2ϩ (10 -13) . This is called agonist-induced "Ca 2ϩ sensitization." Since guanosine 5Ј-O-(3-thiothiphosphate) mimics this effect (14, 15) , it is thought that G-proteins are involved in this mechanism. Since both PKC and Rho are downstream of Gprotein pathways, it is thought that MLCP down-regulation is at least part of the "Ca 2ϩ sensitization" mechanism. It is known that smooth muscle initiates contraction in the absence of Ca 2ϩ when MLCP activity is completely inhibited by the potent phosphatase inhibitor, microcystin (16 -19) . During this process, myosin regulatory light chain is phosphorylated, suggesting that Ca 2ϩ -free contraction with MLCP inhibition is due to an increase in myosin phosphorylation by protein kinases. The question is the identity of such protein kinases. The first candidate is MLCK, since MLCK can phosphorylate myosin in the absence of Ca 2ϩ (20) . However, the activity of MLCK in the absence of Ca 2ϩ is 1/1,000 to 1/10,000 of that in the presence of Ca 2ϩ (20) , and this value is too low to account for the phosphorylation rate observed during Ca 2ϩ free contraction. This view was supported by the recent finding that a MLCK-specific peptide inhibitor failed to inhibit the Ca 2ϩ -free contraction induced by microcystin (19) . Interestingly, the stimulation of smooth muscle by certain agonists induces myosin light chain phosphorylation at both serine and threonine residues, presumably at Ser 19 and Thr 18 (21) (22) (23) . While the serine phosphorylation is higher than the threonine phosphorylation, the extent of threonine phosphorylation is sufficiently high that it cannot be readily explained by MLCK, since it phosphorylates Ser 19 100 times faster than Thr 18 (24) . These findings lead to a hypothesis that protein kinases other than MLCK may contribute to myosin light chain phosphorylation in smooth muscles during agonist-induced contraction.
The question to be answered is which protein kinases are responsible for myosin light chain phosphorylation. In this study, we found that ZIP kinase is expressed in smooth muscle tissues and that it can phosphorylate myosin in a Ca 2ϩ -independent manner and thereby induce Ca 2ϩ -free contraction of permeabilized smooth muscle.
EXPERIMENTAL PROCEDURES
Proteins-Smooth muscle myosin (25) and myosin light chain kinase (26) were prepared from turkey gizzards as described previously. Actin was prepared from rabbit skeletal muscle according to Spudich and Watt (27) . Xenopus oocyte calmodulin (28) and smooth muscle MLC 20 were expressed in Escherichia coli and purified as described (29, 30 Expression of Recombinant ZIP Kinase in Bacteria-A DNA fragment corresponding to the nucleotide residues from 49 to the T7 promoter on the pBluescript SK Ϫ was amplified by polymerase chain reaction using sense primer, which was designed to contain an EcoRI site, and M13 reverse primer as an antisense primer. The EcoRI-and XhoI-digested polymerase chain reaction product was ligated to the EcoRI-and XhoI-digested pGEX4T-2 vector (Amersham Pharmacia Biotech) using T4 ligase. Arg 305 was substituted by stop codon by site-directed mutagenesis. The expression vector was transformed into BL21 codon plus E. coli (Stratagene) and cultured at 30°C until the absorbance at 600 nm reached 0.8 -1.0. Protein expression was induced by the addition of 50 M isopropyl-␤-D-thiogalactopyranoside. Cells were allowed to grow for 2 h and were collected by centrifugation at 3000 ϫ g for 15 min at 4°C. The cells were homogenized in lysis buffer containing 0.5 M NaCl, 2.7 mM KCl, 10 mM Na 2 HPO4, 1.8 mM KH 2 PO 4 , pH 7.4, 1% Triton X-100, 0.05% Brij-35, 0.5% Nonidet P-40, 1 mM EDTA, 1 mM dithiothreitol (DTT), 1 mg/ml lysozyme, 10 g/ml leupeptin, 2 mM phenylmethanesulfonyl fluoride, 0.1 mg/ml trypsin inhibitor, and 10% glycerol. The homogenate was clarified by centrifugation at 10,000 ϫ g for 20 min at 4°C, and the supernatant was mixed for 3-4 h at 4°C with glutathione-Sepharose 4B (Amersham Pharmacia Biotech) equilibrated in phosphate-buffered saline. The resin was extensively washed with phosphate-buffered saline containing 10% glycerol. The bound protein was eluted by 10 mM glutathione, 100 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 g/ml leupeptin, 2 mM phenylmethanesulfonyl fluoride, and 10% glycerol.
Expression of Full-length ZIP Kinase, MBS, and Rho-associated Kinase in Sf9 Cells-Full-length ZIP kinase cDNA was subcloned into pFASTBAC (Life Technologies, Inc.) with glutathione S-transferase (GST) cDNA fused at its NH 2 terminus. Full-length rat MBS cDNA and Rho-kinase cDNA were kind gifts from Dr. P. Cohen (University of Dundee) and Dr. S. Narumiya (Kyoto University), respectively, and were cloned into pFASTBAC HT plasmid. The plasmids were transformed into DH10BAC E. coli. Recombinant bacmids (recombinant virus DNA) were isolated and used to transfect Sf9 insect cells. Proteins were expressed by infection of fresh Sf9 cells with viral stock for 72 h. GST-fused full-length ZIP kinase was purified by glutathione-Sepharose 4B. Hexahistidine-tagged MBS and Rho-kinase were purified using Ni 2ϩ -nitrilotriacetic acid-agarose (Qiagen). Mutant MBS (T641A), in which Thr 641 was mutated to Ala, was made by site-directed mutagenesis using MBS expression vector as a template.
Production of Antibody-Peptides CRRREDGARKPERR (corresponding to the sequence of amino acids 294 -306 of smooth muscle ZIP kinase) and CQSRRSpTQGVTL (where pT represents phosphothreonine) (corresponding to the sequence of amino acids 636 -646 of rat MBS) were chemically synthesized as antigen and bound to the carrier protein, keyhole limpet hemocyanin, at the NH 2 -terminal cysteine residue by Genmed Synthesis Inc. (South San Francisco, CA). Antibody was prepared by injecting two rabbits with keyhole limpet hemocyanincoupled peptide. Antibody against ZIP kinase was affinity-purified from the obtained serum by affinity chromatography with the peptide-conjugated resin. Phosphorylation-specific antibody against MBS phosphorylated at Thr 641 was purified by two-step chromatography, affinity chromatography on phosphopeptide-coupled resin, and then absorption in unphosphorylated peptide-coupled resin.
Biochemical Procedure-Phosphorylation of smooth muscle myosin or isolated MLC 20 was carried out using 1 g/ml GST-ZIPK in the presence of 30 mM Tris-HCl, pH 7.5, 1 mM MgCl 2 , 100 mM NaCl, 1 mM EGTA, 1 mM DTT, 1 M microcystin LR, 0.1 mM [␥-
32 P]ATP (3000 Ci/mmol; PerkinElmer Life Sciences) for the indicated period, and then the reaction was terminated by 10% trichloroacetic acid. Aliquots were subjected to SDS-polyacrylamide gel electrophoresis followed by autoradiography or quantified as described previously (33) . Phosphorylation of myosin by MLCK was carried out using 0.46 g/ml MLCK in the presence of 30 mM Tris-HCl, pH 7.5, 1 mM MgCl 2 , 100 mM NaCl, 0.2 mM CaCl 2 , 1 mM DTT, 1 M microcystin LR, 2 g/ml calmodulin, and 0.1 mM ATP. Phosphoamino acid analysis was done as described previously (24) . The actin-activated Mg 2ϩ -ATPase activity of myosin was determined by measuring the liberated 32 P as described previously (26) . SDS-polyacrylamide gel electrophoresis was carried out on a 7.5-20% polyacrylamide gradient slab gel using the discontinuous buffer system of Laemmli (34) . Western blotting was carried out as described previously (31, 35) . Urea/glycerol electrophoresis was performed as described previously (36) .
Permeabilization, Force Measurement, and Myosin Light Chain Phosphorylation of Rabbit Mesenteric Artery-New
Zealand White rabbits (2.5-3.0 kg) were sacrificed by the injection of pentobarbital (100 mg/kg). Smooth muscle strips were dissected from the first branch of mesenteric arteries. Fat and adventitia were removed mechanically under a binocular microscope, and endothelium was removed by gentle rubbing with a cotton swab. Then mesenteric arteries were cut into strips (50 m thick, 500 m wide, and 3 mm long). Smooth muscle strips were permeabilized with 1% Triton X-100 in 20 mM imidazole, pH 7.4, 50 mM KCl, 5 mM EGTA, 150 mM sucrose, and 0.5 mM DTT for 60 min at 25°C. The strips were tied with silk filaments and suspended between the fine tips of two tungsten needles, one of which was connected to a force transducer (FORT-10, WPI, Sarasoto, FL). The standard relaxing solution used for resting states of the permeabilized strips contains the following: 100 mM potassium methansulfonate, 5.0 mM MgCl 2 , 5.9 mM Na 2 ATP, 10 mM EGTA, 10 mM creatine phosphate, 10 units/ml phosphocreatine kinase, and 20 mM Tris-maleate, pH 6.8. In the activating solution, a calculated amount of calcium methanesulfonate was added to give the final desired concentration of free Ca 2ϩ ions. All solutions were adjusted to pH 6.8 at 25°C. The developed tension was expressed as a percentage, assigning the values in relaxing solution and steady state of 10 M Ca 2ϩ -induced contraction recorded at the end of the experiment as 0 and 100%, respectively. MLC 20 phosphorylation of smooth muscle strips was determined according to the method described by Persechini et al. (37) . The contractile responses were terminated by the immersion of dry ice-cold acetone containing 10% trichloroacetic acid and 10 mM DTT. Proteins were extracted in buffer containing 20 mM Tris, 23 mM glycine, 10 mM DTT, 9 M urea, and 0.002% bromphenol blue and then subjected to urea/glycerol PAGE, followed by immunoblot using 20-kDa myosin light chain antibody or a phosphorylation site-specific antibody for phosphorylated 20-kDa myosin light chain at Ser 19 (38) .
RESULTS

ZIP Kinase in Smooth
Muscle-ZIP kinase was cloned from rat aorta. The deduced amino acid sequence was highly homologous to the ZIP kinase previously cloned from other mammalian species (Fig. 1) . However, the ZIP kinase obtained from rat aorta contained a unique 16 residues at the NH 2 -terminal end of the molecule, with a unique initiation codon. In the nucleotide sequence of ZIP kinase previously reported (39) , there is a stop codon at the Ϫ15-position. In the rat aorta ZIP kinase, this stop codon was not present; instead, a novel 5Ј sequence was found. Based upon this unique extension of the 5Ј sequence, it is concluded that the aorta clone encodes a ZIP kinase with a unique 16-residue extension at the NH 2 -terminal end. Aorta ZIP kinase showed highest homology to the kinase domains of death-associated protein kinase and MLCK (48.6% identical to rabbit smooth muscle MLCK) as previously reported for other ZIP kinases (32, 39, 40), but there is no autoinhibitory region and calmodulin binding region as is present in MLCK, suggesting that this kinase is not a calmodulin-dependent kinase.
The expression of ZIP kinase in smooth muscle was examined by Western blot analysis of various smooth muscle tissues (Fig. 2) . ZIP kinase was found in various types of phasic or tonic smooth muscle tissues. 
Phosphorylation of Smooth Muscle
Myosin by ZIP Kinase-To find whether ZIP kinase can phosphorylate smooth muscle myosin, we expressed and purified the ZIP kinase. ZIP kinase cDNA was inserted into a pGEX-4T-2 expression vector containing the GST gene, and the GST fusion protein was expressed. Fig. 3 shows the expression and purification of GST-ZIP kinase. GST-ZIP kinase was purified to homogeneity with an expected molecular mass of 60 kDa. The authenticity of the 60-kDa band protein as ZIP kinase was confirmed by Western blot analysis with anti-GST antibodies and anti-ZIP kinase antibodies as shown in Fig. 3B . The purified GST-ZIP kinase was examined for phosphorylation of myosin and myosin-regulatory light chain (MLC 20 ). ZIP kinase phosphorylated MLC 20 in a Ca 2ϩ -independent manner. The time course of phosphorylation fits a single saturation curve, suggesting that ZIP kinase phosphorelates MLC 20 with a single rate constant. Consistently, phosphoamino acid analysis revealed that ZIP kinase phosphorylates both serine and threonine residues to a similar extent (Fig. 4B) . Autoradiography confirmed that the incorporation of 32 P is indeed into MLC 20 (Fig. 4C ). Since many protein kinases can phosphorylate MLC 20 when isolated but not while it resides in intact myosin, whole smooth muscle myosin was used as a substrate for ZIP kinase. While the rate of phosphorylation was slightly slower for whole myosin, ZIP kinase phosphorylated intact smooth muscle myosin well at its regulatory light chain (MLC 20 ) . Table I shows the effect of ZIP kinase-induced phosphorylation on the actin-activated ATPase activity of smooth muscle myosin. The activity was significantly enhanced by ZIP kinaseinduced phosphorylation, and the value was comparable with that phosphorylated by MLCK. These results suggest that ZIP kinase phosphorylates the MLCK sites, i.e. Ser 19 and Thr 18 of MLC 20 . To determine the ZIP kinase phosphorylation sites, we produced MLC 20 mutants in which Ser 19 and/or Thr 18 is mutated to Ala (Fig. 5) . The extent of phosphorylation by ZIP kinase of S19A and T18A mutants was approximately half of the wild type (Fig. 5) . For T18A,S19A MLC 20 , the phosphorylation was completely abolished (Fig. 5) (24) , the rate of phosphorylation of the S19A and T18A mutants by ZIP kinase was nearly identical, indicating that ZIP kinase does not have a preference between Ser 19 and Thr 18 . Fig. 6 shows the time course of myosin phosphorylation by ZIP kinase and MLCK. The phosphorylated myosin was examined at various times for the fraction of monophosphorylated and diphosphorylated forms. While MLCK produces the monophosphorylated form exclusively, ZIP kinase produced the diphosphorylated form before saturating the monophosphorylated form. The ratio of the monophosphorylated and diphosphorylated form was plotted against the extent of total phosphorylation. The obtained curve fits random phosphorylation of the two sites with an identical rate constant rather than a sequential phosphorylation. Fig. 7 shows the phosphorylation of MBS by ZIP kinase. Although the kinase domain of ZIP kinase phosphorylated MBS, the phosphorylation level was much lower than that of myosin light chain phosphorylation (Fig. 7A) . MBS phosphorylation by full-length ZIP kinase was lower than the autophosphorylation of ZIP kinase and hardly detected (Fig. 7B) , while myosin was well phosphorylated by ZIP kinase at the regulatory light chain. Phosphorylation of MBS at Thr 641 by the kinase domain of ZIP kinase was examined using site-and phosphorylation-specific antibody. Although the kinase domain of ZIP kinase phosphorylated MBS at Thr 641 , the phosphorylation level was much lower than that by Rho-kinase (Fig. 7D) . The results suggest that while ZIP kinase can phosphorylate MBS at Thr 641 , MBS is not a good substrate for ZIP kinase. Fig. 8 shows that microcystin LR, a potent protein phosphatase inhibitor, induces Ca 2ϩ -free force production in Triton X-100-permeabilized strips of rabbit mesenteric artery. The increase in force was accompanied by myosin light chain phosphorylation (Fig.  8B) . Interestingly, a significant amount of the diphosphorylated myosin light chain was produced during the microcystininduced Ca 2ϩ free contraction. In contrast, practically no diphosphorylated form was produced during high Ca 2ϩ -in- unphosphorylated by GST-ZIP kinase The ATPase activity was measured in the buffer containing 30 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 30 mM KCl, 1 mM EGTA, and 0.1 mg/ml myosin in the presence and absence of 2 mg/ml actin at 25°C. Smooth muscle myosin was phosphorylated by GST-ZIP kinase (1 g/ ml) in the same condition as in Fig. 4 for 60 min at 25°C. After phosphorylation, myosin was precipitated in the presence of 30 mM Tris-HCl, pH 7.5, 30 mM KCl, and 15 mM MgCl 2 and then washed with the same buffer to remove GST-ZIP kinase. Then myosin was resuspended in a buffer containing 30 mM Tris-HCl, pH 7.5, 0.3 M KCl, and 1 mM DDT. duced contraction. The result suggests that different protein kinases are responsible for the phosphorylation of MLC 20 under high Ca 2ϩ conditions versus under Ca 2ϩ -free conditions in the presence of microcystin. Supporting this notion, wortmannin, a potent inhibitor of MLCK, did not inhibit microcystininduced contraction, although wortmannin completely inhibited the Ca 2ϩ -induced contraction (Fig. 8D) . In order to identify the kinase responsible for the Ca 2ϩ -free, microcystin-induced contraction of smooth muscle strips, we examined various protein kinase inhibitors for smooth muscle contraction inhibition. MLCK inhibitors, ML-9 and wortmannin, failed to inhibit the contraction, suggesting that MLCK does not play a role in microcystin-induced force development. Neither H-7 nor chelerythrine inhibited the microcystin-induced contraction, suggesting that PKC is not involved. Rho-kinase, which can phosphorylate myosin in vitro (41) , is not the kinase responsible for microcystin-induced contraction, since a specific inhibitor of Rho-kinase, Y27632, did not affect force production at all (Fig.  8F) . Nevertheless, myosin phosphorylation is required for the contraction, since staurosporine, a potent general protein kinase inhibitor, completely inhibited the microcystin-induced contraction (Fig. 8C ) and this was accompanied by a marked decrease in myosin phosphorylation (not shown). Fig. 9 shows the effect of various protein kinase inhibitors on ZIP kinase activity. Among them, only staurosporine could inhibit ZIP kinase potently. The result is consistent with the inhibition of microcystin-induced force development of smooth muscle strips. Fig. 10A shows the effect of ZIP kinase on the contrac- 20 and mutant MLC 20 (S19A, T18A, and T18A,S19A (TS18,19AA)) were phosphorylated by GST-ZIP kinase for 60 min at 25°C and subjected to SDS-PAGE (left panel) and autoradiography (right panel). B, wild type and mutant MLC 20 were also phosphorylated by GST-ZIP kinase for various periods, and incorporation of 32 P was assayed. The extent of phosphorylation was expressed by percentage, assigning the maximum phosphorylation of wild type MLC 20 (2 mol of phosphates/1 mol of MLC 20 ) to be 100%. Open circles, wild type; squares, S19A; triangles, T18A; closed circles, T18A,S19A.
Effects of ZIP Kinase on the Tension and Myosin Phosphorylation in Permeabilized Smooth Muscle Strips-
FIG. 5. Determination of MLC 20 phosphorylation sites by ZIP kinase. A, wild type (WT) MLC
FIG. 6. Time course of myosin phosphorylation by ZIP kinase and MLCK.
A, smooth muscle myosin (1 mg/ml) was phosphorylated by GST-ZIP kinase (0.36 g/ml) (upper panel) or MLCK (0.46 g/ml) (lower panel) for the indicated time and then subjected to the urea/glycerol PAGE. B, the extent of myosin phosphorylation by ZIP kinase was determined by densitometry. The proportion of unphosphorylated (open circles), monophosphorylated (closed circles) and diphosphorylated (closed squares) was plotted against the total amount of phosphorylated MLC 20 . The curves were obtained by the simulation, where phosphorylation of both sites occurred randomly with an identical rate constant. tion of smooth muscle strips. The addition of purified ZIP kinase to the Triton X-100-permeabilized smooth muscle strip induced Ca 2ϩ -free contraction in the absence of microcystin. Furthermore, MLC 20 phosphorylation increased significantly during the ZIP kinase-induced contraction. This is because exogenously added ZIP kinase overweighed the myosin phosphatase activity. It should be noted that ZIP kinase-induced myosin phosphorylation in strips yielded a significant amount of the diphosphorylated species, similar to the microcystininduced contraction but not the Ca 2ϩ -induced contraction (Fig.  8B) . Consistent with the results above, ZIP kinase was found to be present in Triton X-100-skinned fibers. The immunoreactivities from intact and skinned fibers were nearly identical, suggesting that almost all of ZIP kinase remained in the skinned fibers. This result suggests that ZIP kinase associates with the filamentous components in smooth muscle. The results obtained in the present study indicate that ZIP kinase is involved in the microcystin-induced Ca 2ϩ free contraction of smooth muscle, thus contributing to the basal level of myosin phosphorylation in the resting state.
DISCUSSION
It has been known that smooth muscle contracts even in the absence of Ca 2ϩ if protein phosphatase inhibitors such as okadaic acid (16, (42) (43) (44) , calyculin A (45, 46) , tautomycin (16, 47) , or microcystin (16 -19) are added. Recently, Weber et al. (19) reported that microcystin induced Ca 2ϩ -free contractions of Triton X-100-skinned rat caudal arterial smooth muscle and that during the Ca 2ϩ -free contraction, myosin regulatory light chain was phosphorylated at both Ser 19 and Thr 18 . The present study confirms these earlier results and furthermore provides evidence that ZIP kinase is involved as follows. 1) ZIP kinase phosphorylates intact myosin at both Ser 19 and Thr 18 of the regulatory light chain, thus activating the actin-activated ATPase activity of myosin (32) . 2) ZIP kinase phosphorylates both Ser 19 and Thr 18 with the same rate constant, which is different from other protein kinases phosphorylating myosin. This is consistent with the microcystin-induced phosphorylation of myosin light chain in fibers under Ca 2ϩ -free conditions, in which a significant amount of the diphosphorylated form is observed. The relative amounts of the monophosphorylated and the diphosphorylated forms are consistent with the fact that ZIP kinase phosphorylates Ser 19 and Thr 18 by an identical 20 at the sustained phase of ZIP kinaseinduced contraction was monitored by urea/glycerol PAGE followed by Western blot as described in Fig. 8 . P0, P1, and P2 denote unphosphorylated, monophosphorylated, and diphosphorylated MLC 20 , respectively. C, endogenous ZIP kinase content in smooth muscle strips. Triton X-100 treatment did not eliminate the endogenous ZIP kinase. Intact and Triton X-100-permeabilized strips were subjected to Western blot analysis using anti-ZIP kinase antibodies. Approximately 20 g of total protein was loaded. The amount of proteins loaded to SDS-PAGE was normalized by actin content. rate. 3) ZIP kinase is expressed in smooth muscle and is present in Triton X-100-permeabilized strips. 4) ZIP kinase has a Ca 2ϩ -independent activity. 5) Inhibition of the microcystininduced Ca 2ϩ free contraction of strips by various protein kinase inhibitors is consistent with the inhibition of ZIP kinase by these inhibitors. 6) The addition of ZIP kinase evoked Ca 2ϩ -free contraction of Triton X-100-skinned smooth muscle fibers, even in the absence of microcystin.
It was previously thought that Ca 2ϩ -free contraction of skinned smooth muscle strips in the presence of MLCP inhibitors was due to a Ca 2ϩ -independent form of MLCK (46) that can be produced during the skinning process by proteolytic degradation (48) . Furthermore, the PKC inhibitor chelerythrine failed to inhibit the Ca 2ϩ -free contraction in the presence of microcystin. mitogen-activated protein kinase-activated protein kinase 2, p21-activated kinase, and Rho-kinase also phosphorylate Ser 19 exclusively. The Rho kinase inhibitor, Y27632, did not inhibit microcystin-induced Ca 2ϩ -free contractions. These results suggest that the kinases previously found to phosphorylate myosin are not responsible for Ca 2ϩ -free myosin phosphorylation in smooth muscle. While this paper was in preparation, Deng et al. (52) purified integrin-linked kinase as a Ca 2ϩ -independent myosin light chain kinase in chicken gizzard. This kinase showed significantly higher kinase activity to isolated myosin light chain than intact myosin in contrast to ZIP kinase, which has similar activity to both isolated light chain and intact myosin. Although it was shown that the majority of integrin-linked kinase activity was recovered in the Triton-insoluble fraction, whether integrin-linked kinase actually induces Ca 2ϩ -free contraction is not known. It should be noted that a significant amount of the Ca 2ϩ -independent myosin light chain kinase activity was observed in the non-integrin-linked kinase-containing fractions, suggesting that there are multiple kinases contributing to the Ca 2ϩ -independent myosin light chain kinase activity in smooth muscle. Clearly, ZIP kinase is one such Ca 2ϩ -independent myosin light chain kinase, and since nearly 100% of ZIP kinase is retained in Triton X-100-skinned fiber and exogenously added ZIP kinase induced Ca 2ϩ -free myosin phosphorylation and muscle contraction, it can be concluded that ZIP kinase plays a significant role in Ca 2ϩ -free myosin phosphorylation and contraction. The present result indicates that smooth muscle ZIP kinase associates with Triton X-100-insoluble materials. Since ZIP kinase has a leucine zipper motif at its COOH-terminal region, it is plausible that ZIP kinase associates with the smooth muscle components via its leucine zipper domain. While this paper was in preparation, it was reported (53) that ZIP kinase associates with a large subunit of MLCP that is supposed to be associated with smooth muscle myosin. It should be noted that the two noncatalytic subunits of MLCP (i.e. MBS and M20) also contain a leucine zipper domain. These findings raise the possibility that ZIP kinase associates with myosin and readily phosphorylates smooth muscle myosin in situ. It was also shown (53) that a fragment of ZIP kinase can phosphorylate MBS at the inhibitory site (Thr 695 in gizzard sequence). We examined phosphorylation of MBS by both a kinase domain and a full-length ZIP kinase. In both cases, the phosphorylation of MBS by ZIP kinase was much lower than that of myosin (Fig.  7) , suggesting that MBS is not a good substrate for ZIP kinase. Western blot analysis using phosphorylation-specific antibody, which recognizes phosphorylated MBS at Thr 641 , which corresponds to Thr 695 of chicken M133, showed that ZIP kinase phosphorylated MBS at Thr 641 , which is consistent with the report by MacDonald et al. (53) . However, the phosphorylation level at Thr 641 was much lower than that by Rho-kinase (Fig.  7D) , suggesting that the inhibitory effect of ZIP kinase on myosin phosphatase would be much weaker than that of Rho-kinase.
It has been known that the stimulation of intact smooth muscle by certain agonists induces significant phosphorylation of myosin regulatory light chains at a Thr site in addition to a Ser site (21) (22) (23) . The large extent of threonine phosphorylation has been puzzling, since MLCK exclusively phosphorylates the serine site and the rate for serine site phosphorylation is over 100-fold that for threonine phosphorylation (24) . A likely scenario would be that a protein kinase phosphorylating both serine and threonine sites of myosin regulatory light chain is activated during agonist stimulation in smooth muscles and that it contributes to the increase in myosin light chain phosphorylation and, thus, contraction. ZIP kinase is a good candidate for just such a protein kinase.
